Research programme: infectious disease vaccines - Aparna Biosciences
Latest Information Update: 28 Aug 2020
At a glance
- Originator Aparna Biosciences
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Infections
Highest Development Phases
- No development reported Infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Infections in USA
- 21 Jul 2016 Research programme: infectious disease vaccines - Aparna Biosciences is available for licensing as of 21 Jul 2016. http://www.aparnabio.com/
- 21 Jul 2016 Early research in Infections in USA (unspecified route)